This is a renewal application for the operation of the core facilities of the Reproductive Endocrinology Center of the University of California, San Francisco. the core facilities include: (1) Assay Laboratory, (2) Molecular Biology Core, (3) Morphology Core, (4) Microcomputer Facility, (5) Primate Facility, (6) Analytical Separation Core, and (7) Administrative Core. The Reproductive Endocrinology Center is an integrated, interdepartmental research and training program at the University of California, San Francisco. It was established to study hormonal regulation of reproductive events at the subcellular, cellular, tissue and whole organism levels. A variety of species, including subhuman primates and humans, is being studied with the overall goal being to understand the physiologic and pathophysiologic regulation of the reproductive process in humans. More specifically, this is a multifaceted program with primary foci being studies of the hypothalamic-pituitary-gonadal-target tissue axis and the endocrine physiology of pregnancy. In addition to its longstanding foci on protein and steroid biochemistry, clinical investigation, and developmental and reproductive biology, there has been progressively increasing activity in the Center in the areas of reproductive neurosciences as well as cell and molecular biology. Currently, there are 16 faculty members on the staff of the Reproductive Endocrinology Center from the following Departments and Organized Research Units: Obstetrics, Gynecology and Reproductive Sciences, Anatomy, Physiology, Biochemistry and Biophysics, Pathology, Laboratory of Molecular Endocrinology and Cancer Research Institute. The existence of the core facilities has permitted the maximal development and use of frequently employed research procedures, has increased collaboration and interchange between the members of the Reproductive Endocrinology Center, has avoided unnecessary duplication, and thus has been, and continues to be, cost-effective.

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Center Core Grants (P30)
Project #
Application #
Study Section
Population Research Committee (HDPR)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
Schools of Medicine
San Francisco
United States
Zip Code
Hornung, D; Lebovic, D I; Shifren, J L et al. (1998) Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil Steril 69:909-15
Baker, V L; Chao, V A; Murai, J T et al. (1997) Human umbilical vessels and cultured umbilical vein endothelial and smooth muscle cells lack detectable protein and mRNA encoding estrogen receptors. J Soc Gynecol Investig 4:316-24
Shifren, J L; Tseng, J F; Zaloudek, C J et al. (1996) Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81:3112-8
Coulter, C L; Goldsmith, P C; Mesiano, S et al. (1996) Functional maturation of the primate fetal adrenal in vivo. II. Ontogeny of corticosteroid synthesis is dependent upon specific zonal expression of 3 beta-hydroxysteroid dehydrogenase/isomerase. Endocrinology 137:4953-9
Gordon, J D; Mesiano, S; Zaloudek, C J et al. (1996) Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 81:353-9
Plosker, S M; Rabinovici, J; Montalvo, M et al. (1995) Endogenous catecholamines suppress thyrotropin secretion during the early follicular phase of the menstrual cycle. J Clin Endocrinol Metab 80:2530-3
Cataldo, N A; Rabinovici, J; Fujimoto, V Y et al. (1994) Follistatin antagonizes the effects of activin-A on steroidogenesis in human luteinizing granulosa cells. J Clin Endocrinol Metab 79:272-7
Jaffe, G J; Harrison, C E; Lui, G M et al. (1994) Activin expression by cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 35:2924-31
Marshall, L A; Fluker, M R; Jaffe, R B et al. (1991) Inhibition of follicular development by a potent antagonistic analog of gonadotropin-releasing hormone (detirelix). J Clin Endocrinol Metab 72:927-33
Marshall, L A; Martin, M C; Leong, S et al. (1988) Influence of preovulatory estradiol concentration on diurnal and pulsatile prolactin secretion patterns. Am J Obstet Gynecol 159:1558-63

Showing the most recent 10 out of 12 publications